​

Funding Round

Series C - Interlace Medical

Series C - Interlace Medical

Investment Firm

Overview

Interlace Medical develops devices for interventional gynecologists to perform office-based procedures instead of surgery to treat diseases.

Announced Date

Jul 07, 2009

Funding Type

Series C

Highlights

Location

United States, North America

Social

N/A

Investor Lead

Baird Capital

Baird Capital

Baird Capital is a debt and early_stage_venture and late_stage_venture and private_equity firm.

HLM Venture Partners

HLM Venture Partners

HLM Venture Partners is a debt and early_stage_venture and late_stage_venture and post_ipo and seed and venture firm.

Participant Investors

6

Investor Name
Participant InvestorHQ Capital
Participant InvestorAperture Venture Partners
Participant InvestorNew Leaf Venture Partners
Participant InvestorHLM Venture Partners
Participant InvestorBaird Capital

Round Details and Background

Interlace Medical raised $20500000 on 2009-07-07 in Series C

Interlace Medical develops devices for interventional gynecologists to perform office-based procedures instead of surgery to treat diseases.

Company Funding History

4

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Aug 11, 2006
Series A - Interlace Medical
2-750.0K
Jul 23, 2008
Series B - Interlace Medical
2-7.0M
May 21, 2007
Series B - Interlace Medical
2-3.0M
Jul 07, 2009
Series C - Interlace Medical
6-20.5M

Recent Activity

There is no recent news or activity for this profile.